Argentina vs Italy: Access to anti-retroviral drugs, female
Argentina
89.0%
in 2024
Italy
89.0%
in 2023
Argentina rank
35th
Italy rank
35th
Access to anti-retroviral drugs, female over time
- Argentina
- Italy
How they compare
Argentina currently reports 89.0% against 89.0% in Italy, a difference of 0.0%.
Across all 24 years both countries report, Italy has been ahead every year.
Argentina ranks 35th and Italy ranks 35th of 141 countries.
Italy has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.5% | 52.5% | 22.0% | Italy |
| 2010s | 61.0% | 81.0% | 20.0% | Italy |
| 2020s | 81.0% | 89.2% | 8.2% | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Argentina or Italy?
- Argentina, at 89.0% against 89.0% in Italy as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Argentina and Italy?
- 0.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Italy?
- 24 years are reported by both, from 2000 to 2023.
- How do Argentina and Italy rank globally for access to anti-retroviral drugs, female?
- Argentina ranks 35th and Italy ranks 35th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.